New drug combo shows promise for rare sarcomas
NCT ID NCT03526679
First seen Jan 03, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tested a combination of two drugs, lenvatinib and eribulin, in 30 adults with advanced sarcoma (a type of cancer) that could not be removed by surgery. The goal was to see if the combination could shrink tumors or stop them from growing. The drugs work by cutting off the tumor's blood supply and attacking cancer cells directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan, Taiwan
Conditions
Explore the condition pages connected to this study.